Q/C Technologies, Inc. SEC filings QCLS
Q/C Technologies, Inc. has 604 filings in SEC EDGAR's recent list, going back to Mar 23, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (material agreement, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Feb 11, 2026 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| S-3 | Shelf registration | Oct 3, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| S-3/A | Filing | Aug 8, 2024 | — |
| S-3 | Shelf registration | Jun 21, 2024 | — |
| 424B5 | Prospectus supplement | Feb 23, 2023 | — |
| 424B5 | Prospectus supplement | Aug 17, 2022 | — |
| S-8 | Employee stock plan registration | Jul 5, 2022 | — |
| 424B3 | Prospectus | May 11, 2021 | — |
| S-3/A | Filing | Apr 28, 2021 | — |
| S-3 | Shelf registration | Mar 25, 2021 | — |
| 424B3 | Prospectus | Mar 23, 2021 | — |
| S-4/A | Filing | Mar 19, 2021 | — |
| S-4 | Registration for a merger or exchange | Jan 15, 2021 | — |
| 424B3 | Prospectus | Sep 8, 2020 | — |
| S-3 | Shelf registration | Aug 18, 2020 | — |
| 424B5 | Prospectus supplement | Aug 13, 2020 | — |
| S-3/A | Filing | Jun 5, 2020 | — |
| S-3 | Shelf registration | May 22, 2020 | — |
| 424B5 | Prospectus supplement | May 18, 2020 | — |
| 424B5 | Prospectus supplement | Apr 8, 2020 | — |
| S-3/A | Filing | Apr 7, 2020 | — |
| 424B4 | Prospectus | Dec 9, 2019 | — |
| S-1MEF | Filing | Dec 5, 2019 | — |
| S-1/A | Amended registration statement | Dec 4, 2019 | — |
| S-1/A | Amended registration statement | Nov 29, 2019 | — |
| S-3 | Shelf registration | Nov 1, 2019 | — |
| S-1 | Registration statement | Nov 1, 2019 | — |
| 424B5 | Prospectus supplement | Nov 2, 2018 | — |
| 424B4 | Prospectus | Dec 20, 2017 | — |
| S-1/A | Amended registration statement | Dec 18, 2017 | — |
| S-1/A | Amended registration statement | Dec 18, 2017 | — |
| S-1/A | Amended registration statement | Dec 15, 2017 | — |
| S-1/A | Amended registration statement | Dec 14, 2017 | — |
| FWP | Free writing prospectus | Dec 11, 2017 | — |
| S-1/A | Amended registration statement | Dec 11, 2017 | — |
| S-1 | Registration statement | Nov 24, 2017 | — |
| 424B5 | Prospectus supplement | Oct 16, 2017 | — |
| 424B3 | Prospectus | Jul 20, 2017 | — |
| S-3/A | Filing | Jun 26, 2017 | — |
| S-3 | Shelf registration | Apr 19, 2017 | — |
| 424B5 | Prospectus supplement | Jan 10, 2017 | — |
| 424B5 | Prospectus supplement | Jan 6, 2017 | — |
| FWP | Free writing prospectus | Nov 16, 2016 | — |
| 424B5 | Prospectus supplement | Nov 16, 2016 | — |
| 424B5 | Prospectus supplement | Nov 16, 2016 | — |
| S-3/A | Filing | Nov 15, 2016 | — |
| S-3 | Shelf registration | Oct 24, 2016 | — |
| 424B3 | Prospectus | Jan 23, 2014 | — |
| S-1/A | Amended registration statement | Jan 23, 2014 | — |
| S-1/A | Amended registration statement | Jan 23, 2014 | — |
| FWP | Free writing prospectus | Dec 31, 2013 | — |
| S-1/A | Amended registration statement | Dec 30, 2013 | — |
| S-1/A | Amended registration statement | Dec 6, 2013 | — |
| S-1/A | Amended registration statement | Nov 18, 2013 | — |
| S-1/A | Amended registration statement | Nov 1, 2013 | — |
| S-1/A | Amended registration statement | Oct 8, 2013 | — |
| S-1 | Registration statement | Aug 7, 2013 | — |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- QCLS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1321834
- Former names
- Q/C TECHNOLOGIES, INC. (until Oct 2, 2026); TNF Pharmaceuticals, Inc. (until Sep 10, 2025); MyMD Pharmaceuticals, Inc. (until Jul 1, 2024); Akers Biosciences, Inc. (until Apr 16, 2021); Akers Biosciences Inc (until Apr 11, 2017)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.